Essex Capital Arranges Preferred Equity Deal
Tampa, Florida, October 8, 2007 - Essex Capital Group, Inc., a private investment banking firm located in Tampa, FL, announced today that it recently arranged a $4.05 million preferred equity investment for Advanced Bio-Technologies Inc. (“ABT”). ABT is a dermatological products company that markets Kelo-cote, a patented fast-drying silicone-based range of products for treatment of scars.
The new investment capital was provided by a Southeast-based private equity group to fund a shareholder buyout and expand the company’s sales and marketing capacity in the United States.
Essex Capital President, Robert Swain, commented, “We were excited to work with ABT to arrange needed growth capital. The company has developed a highly effective scar treatment product that is currently widely distributed in Europe. This equity injection will allow the company to further build out their United States footprint.”
ABT has since relocated its headquarters from Silverdale, WA to St. Petersburg, FL, where it will centralize all corporate functions.
About Essex Capital Group, Inc.
Essex Capital Group, Inc. is a Tampa, Florida-based investment banking firm founded to provide financial advisory services to small and middle market privately-held companies located throughout the United States. Essex focuses on advising business owners regarding the sale or recapitalization of their companies, including arranging private placements of equity, mezzanine debt and senior debt.
- Contact Information
- Robert Swain
- Essex Capital Group, Inc.
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.